Viruses and bacteria are always trying to sneak into our bodies, but researchers at the University of Missouri are ...

The study shows that the SARS-CoV-2 spike protein remains in the brain’s protective layers, the meninges, ... The spike protein binds to so-called ACE2 receptors, ...

A new Yale study has found a promising target for treating the brain fog that can follow COVID-19 and offers new insight into ...

Invivyd, SPEAR Study Group to assess the effects of monoclonal antibody therapy for recent Covid & Covid-19 post-vaccination syndrome: Waltham, Massachusetts Saturday, July 5, 202 ...

A newer COVID-19 variant may be causing a severe sore throat in those who contract the infections. Here's what to know about ...

Persistent Spike Protein: Some PVS participants had detectable SARS-CoV-2 spike protein in their bloodstream up to 709 days post-vaccination, mirroring patterns seen in long COVID cases.

In December 2024, a rumor began spreading online that a team of researchers at Yale University had found the "spike protein" of the SARS-CoV-2 virus, which is responsible for the COVID-19 illness ...

By Dr. Priyom Bose, Ph.D. A new study reveals how targeted electromagnetic waves can disrupt the SARS-CoV-2 spike protein, potentially opening doors to innovative disinfection and infection ...

The SPEAR Study Group will structure and guide anticipated clinical trials evaluating the effects of broadly neutralizing anti-SARS-CoV-2 spike protein monoclonal antibody (mAb) therapy in people ...